The SPECTRALIS® confocal scanning laser ophthalmoscope (cSLO) i is an innovative technology for imaging the retina and other eye structures. Combining the selectivity of laser light with the pinpoint resolution of confocal scanning, the cSLO provides image detail and clarity not available from fundus photography. The cSLO technology not only offers documentation of clinical findings but also often highlights critical diagnostic details not visible on traditional clinical ophthalmoscopy. Since cSLO imaging minimises the effects of light scatter, it can be used effectively even in patients with media opacities or small pupils.

Facilitating the capture of high-quality images is SPECTRALIS® Noise Reduction. Noise Reduction is a proprietary technology that captures multiple images in the exact same anatomic location to remove the noise inherent in OCT and scanning laser imaging. By averaging up to 100 B-scans in real-time, Noise Reduction can differentiate structural information from noise and deliver high contrast images of exceptional detail, even in volume scans.

SHIFT is an exclusive technology with SPECTRALIS that optimises the performance of OCT Angiography Module without sacrificing image quality to deliver individualised patient care, at two scan speeds – 125 kHz or 85 kHz. With a speed-quality ratio optimised for OCTA and combined with TruTrack Active Eye Tracking, the preset scan speed of 125 kHz helps you visualise blood flow in fine capillaries while avoiding artefacts due to natural eye motion.  With SHIFT technology, adapt the examination to the specific needs of your patient with the flexibility to increase the speed when more rapid image acquisition is beneficial or decrease the speed for the capture of clinically meaningful images, even in challenging cases. 

Using the SPECTRALIS® fundus image like a map, the AutoRescan function automatically places follow-up scans in precisely the same position, visit after visit. Accurate and objective placement of follow-up scans is important for optimising clinic workflow and for confident recognition of the small structural changes that are critical to the effective management of many ophthalmic conditions. Studies have shown that SPECTRALIS with AutoRescan technology can reliably measure changes in retinal thickness as small as 1 micron.

The unique combination of SPECTRALIS® imaging modalities provides the additional information you need to make confident clinical decisions. Build a multimodality imaging device based on your clinical requirements and use various imaging techniques simultaneously to improve your understanding of different pathologies. Benefit from deep clinical insight and efficient workflows without needing to move patients between devices and examination rooms.

SPECTRALIS® is a truly flexible and upgradeable imaging platform. Customise SPECTRALIS precisely to your individual needs, confident in the knowledge that your imaging platform has the capability to grow with your clinic. As new technology becomes available, you can simply add new imaging modalities to your SPECTRALIS that provide additional diagnostic information for enhanced clinical decision-making. Many upgrades can be seamlessly integrated into the platform, without the need to invest in new devices, preserving patient data for precise follow-up, and future-proofing your investment.